Skip to main content
. Author manuscript; available in PMC: 2009 Feb 17.
Published in final edited form as: Chest. 2008 Jul 18;134(3):546–551. doi: 10.1378/chest.07-3126

Table 2.

Association Between ICS Usage and Subsequent Mortality Among 2,671 Women With Persistent Asthma, by Major Category of Death (1998–2003)*

Mortality
Variables All-Cause Cardiovascular Cancer Other
Deaths 87 22 31 34
Participants 2,671 2,606 2,615 2,618
Adjustments
 Age 0.63 (0.41–0.98) 0.43 (0.17–1.07) 0.72 (0.35–1.47) 0.71 (0.36–1.41)
 Age and severity 0.57 (0.36–0.90) 0.36 (0.14–0.96) 0.69 (0.33–1.44) 0.60 (0.29–1.23)
 Age, severity, and smoking 0.59 (0.37–0.93) 0.37 (0.14–0.98) 0.69 (0.33–1.44) 0.60 (0.29–1.24)
Multivariate 0.58 (0.36–0.92) 0.37 (0.14–0.99) 0.66 (0.32–1.38) 0.62 (0.30–1.27)
*

Values are given as No. or OR (95% CI).

The multivariate models for all-cause and cardiovascular mortality are adjusted for age, persistent asthma severity, smoking status, history of heart disease, history of cancer, history of stroke, aspirin frequency, and statin use. The multivariate models for cancer and other mortality are adjusted for all factors above except history of heart disease.